Hong Kong · Delayed Price · Currency is HKD Dawnrays Pharmaceutical (Holdings) Company Description
Dawnrays Pharmaceutical (Holdings) Limited, an investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally.
It operates through two segments, Intermediates and Bulk Medicines; and Finished Drugs. The company offers antibiotics, including pharmaceutical intermediates, bulk medicines, powder for injections, cephalosporin tablets, and other oral solid-dosage-form antibiotics.
It also provides system specific medicines comprising cardiovascular systems; anti-HBV, anti-allergic, and digestive systems; urinary systems; anti-hypertensive, antihyperlipidemic, and antiviral; and endocrine system drugs in the form of tablets, capsules, and granules.
Dawnrays Pharmaceutical (Holdings) Limited was founded in 1995 and is headquartered in Wan Chai, Hong Kong.
| Country | Cayman Islands |
| Founded | 1995 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 1,116 |
| CEO | Liwei Yu |
Contact Details
Address: CNT Tower Wan Chai Hong Kong | |
| Phone | 852 2111 9708 |
| Website | dawnrays.com |
Stock Details
| Ticker Symbol | 2348 |
| Exchange | Hong Kong Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | KYG2687M1006 |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Liwei Yu | Chief Executive Officer |
| Kei Ling Li | Co-Founder and Executive Chairman |
| Yung Lai Hung | Co-Founder and Executive Director |
| Yi Jun Wu | Chief Financial Officer |
| Kit Ling Pang CPA | Company Secretary |